Integrated Prostate Cytomolecular Testing
A prostate-focused diagnostic service that integrates cytologic and molecular information into a more structured and clinically useful report.
Learn more →BioVantra brings together cytomolecular testing, cancer estimation and mapping, and digital pathology and reporting support in a structured, prostate-focused workflow for urologists and other clinicians involved in the diagnosis, surveillance, and treatment planning of prostate and bladder cancer.
Four offerings that work on their own or together — from testing through structured report delivery.
A prostate-focused diagnostic service that integrates cytologic and molecular information into a more structured and clinically useful report.
Learn more →A structured interpretation service designed to clarify cancer extent, lesion distribution, and treatment-planning relevance.
Learn more →A non-invasive diagnostic offering that combines urine cytology and molecular analysis in a single integrated report to support bladder cancer detection and surveillance.
Learn more →Digital pathology and synoptic reporting support intended to improve diagnostic clarity, consistency, and communication.
Learn more →Our work is shaped around one clinical area. That focus shows up in how our tests, estimation tools, and reporting come together for urologists and other healthcare professionals involved in the diagnosis, surveillance, and treatment planning of prostate and bladder cancer.
Our work is shaped around prostate cancer diagnosis, alongside bladder cancer detection and surveillance through urothelial cytomolecular testing.
Cytologic, molecular, and pathology information are brought together into one coherent diagnostic view rather than reported in isolation.
Synoptic formats and consistent terminology are used to present findings in a way that is easier to read, compare, and act on.
Outputs are designed to fit into how urologists and other clinicians involved in diagnosis and treatment already work, from testing through structured report delivery.
A short selection of materials explaining our approach. The full library lives on the Resources page.
A short introduction to how cytologic and molecular information are brought together in a prostate-focused diagnostic report.
How structured estimation and zonal mapping can support interpretation of cancer extent and treatment planning.
How a combined cytology and molecular workflow can support bladder cancer detection and surveillance in routine care.
An outline of how synoptic reporting and digital pathology tools are intended to support diagnostic clarity and consistency.
We work with urology practices and clinical teams involved in the diagnosis and treatment of prostate and bladder cancer. Share a little about your setting and a member of our team will follow up.